EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Ceramides in Metabolic and Cardiovascular Diseases

Manuel Gonzalez-Plascencia iD, Idalia Garza-Veloz iD, Virginia Flores-Morales iD, Margarita L Martinez-Fierro iD

Journal of Cardiovascular Development and Disease · 04.01.2026 · 13 (1) · 30

DOI: 10.3390/jcdd13010030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 04.01.2026. Verfasst von Manuel Gonzalez-Plascencia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajar…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ceramides are bioactive sphingolipids increasingly recognized as mediators of cardiometabolic disease and residual cardiovascular risk. Accumulating evidence from experimental and clinical studies indicates that specific ceramide species contribute to insulin resistance, endothelial dysfunction, myocardial injury, and adverse cardiovascular outcomes. In particular, long-chain ceramides (C16:0, C18:0, C20:0 Cer) are consistently associated with myocardial infarction, heart failure, and cardiovascular mortality, whereas very-long-chain ceramides (C22:0, C24:0 Cer) exhibit neutral or potentially protective associations. This narrative review integrates biochemical, experimental, and clinical evidence to examine ceramide metabolism, molecular diversity, and their emerging role as biomarkers for cardiovascular risk stratification. We also discuss ceramide-based risk scores and their potential clinical utility beyond traditional lipid parameters. Understanding the structure–function relationships of ceramides may support the development of novel diagnostic and therapeutic strategies in cardiovascular prevention.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscardiovascular diseasecardiovascular riskceramidesmetabolismsphingolipids

Autor:innen und Institutionen

  • Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.

ORCID-Profile: Manuel Gonzalez-Plascencia, Idalia Garza-Veloz, Virginia Flores-Morales, Margarita L Martinez-Fierro

Zitieren

APA

Gonzalez-Plascencia, M., Garza-Veloz, I., Flores-Morales, V., & Martinez-Fierro, M. L. (2026). The Role of Ceramides in Metabolic and Cardiovascular Diseases. Journal of Cardiovascular Development and Disease, 13(1), 30. https://doi.org/10.3390/jcdd13010030

Vancouver

Gonzalez-Plascencia M, Garza-Veloz I, Flores-Morales V, Martinez-Fierro ML. The Role of Ceramides in Metabolic and Cardiovascular Diseases. Journal of Cardiovascular Development and Disease. 2026;13(1):30. doi:10.3390/jcdd13010030

BibTeX
@article{GonzalezPlascencia2026,
  author = {Gonzalez-Plascencia, Manuel and Garza-Veloz, Idalia and Flores-Morales, Virginia and Martinez-Fierro, Margarita L},
  title = {The Role of Ceramides in Metabolic and Cardiovascular Diseases},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {30},
  doi = {10.3390/jcdd13010030}
}
Kostenlos starten →